Shareholders are scheduled to vote on Novartis’s planned spin-off of its Alcon eye care unit. On Thursday, at the annual general meeting of Swiss drugmaker Novartis, shareholders came in heavily at the drugmaker for the hike in drug prices. Novartis… Read More ›
Alcon
Swiss pharmaceutical giant Novartis to divest its Alcon eye care devices business
The move is aimed at sharpening it focus on its prescription drugs business. On Friday, Novartis disclosed its plans of divesting all of its assets from its Alcon eye care devices business as it sharpens its focus on prescription drugs…. Read More ›